CD93 Blockade Stabilizes Tumor Vasculature to Improve Therapy Response

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Tumor vasculature is often abnormal, hindering drug delivery and immune cell infiltration.
• The CD93/IGFBP7 pathway plays a role in regulating vascular development and function.

Purpose of the Study:

• To investigate the role of the CD93/IGFBP7 pathway in tumor vasculature.
• To determine if disrupting this pathway can improve anti-tumor immunity.

Main Methods:

• Utilized genetically engineered mouse models and in vivo imaging techniques.
• Analyzed tumor tissue for vascular structure and immune cell composition.

Main Results:

• Disruption of the CD93/IGFBP7 pathway led to normalization of tumor blood vessels.
• Increased infiltration of cytotoxic T lymphocytes and other immune cells into tumors was observed.

Conclusions:

• The CD93/IGFBP7 pathway is a critical regulator of tumor vascular normalization.
• Targeting this pathway represents a promising therapeutic strategy to enhance cancer immunotherapy.